HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

2- acetylthiomethyl- 3- (4- methylbenzoyl)propionic acid

suppresses lymphocyte activating factor activity or biosynthesis; structure given in first source
Also Known As:
KE 298; KE-298; esonarimod; Benzenebutanoic acid, alpha-((acetylthio)methyl)-4-methyl-gamma-oxo-
Networked: 8 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Higaki, M: 2 articles (06/2001 - 05/2001)
2. Inoue, T: 2 articles (06/2001 - 05/2001)
3. Takeshita, Kimiyo: 1 article (02/2002)
4. Yodoi, Junji: 1 article (02/2002)
5. Sugimoto, Masanori: 1 article (02/2002)
6. Inoue, Tomoyuki: 1 article (02/2002)
7. Nakamura, Hajime: 1 article (02/2002)
8. Migita, K: 1 article (07/2001)
9. Kamachi, M: 1 article (07/2001)
10. Nakashima, T: 1 article (07/2001)

Related Diseases

1. Rheumatoid Arthritis
2. Arthritis (Polyarthritis)
3. Experimental Arthritis
4. T-Cell Leukemia (Leukemia, T Cell)
5. Hypersensitivity (Allergy)

Related Drugs and Biologics

1. KE 758
2. Interleukins
3. Metalloproteases (Metalloproteinases)
4. Collagen Type II (Type II Collagen)
5. Matrix Metalloproteinases
6. Matrix Metalloproteinase 1 (Interstitial Collagenase)
7. Chemokine CCL5
8. Cytokines
9. Interleukin-6 (Interleukin 6)
10. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)